Halozyme Therapeutics Inc at Goldman Sachs Healthcare Conference Transcript

Jun 13, 2023 / 03:00PM GMT
Corinne Jenkins - Goldman Sachs Group, Inc., Research Division - VP

Great. Welcome to day 2 of the Goldman Sachs 44th Annual Healthcare Conference. Before we get started this morning, we are required to make certain disclosures and public appearances about Goldman Sachs relationships with companies that we discuss. The disclosures relate to investment, banking relationships, compensation received or 1% or more ownership.

We are prepared to read aloud disclosures for any issuer during the sessions upon your request. However, these disclosures are available in our most recent reports available to U.S. clients on our firm's portal. In addition, updates to those disclosures are available by ticker on the firm's public website at www.gs.com.

Goldman Sachs agrees to host this conference on the basis that no third-party speaker will provide confidential or material nonpublic information. In addition, by attending this conference, you provide Goldman Sachs the right to record and redistribute the conference information. The views of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
4.6 out of 5 Trustpilot